On the other hand, Nishiguchi et al reported that long-term IFN-α therapy after curative resection of HCV-related HCC prolongs the survival rate, although preventive effect of intrahepatic recurrence was marginal [33]. Here, IFNA17 is linked to hepatocellular carcinoma.